Conlin Matthew → Fluent, Inc. FLNT

Item 4 of the Schedule 13D is amended by adding the following paragraphs to the end of such item: On December 2, 2024, the Reporting Person acquired the following pre-funded warrants (the "December Pre-Funded Warrants"): (i) December Pre-Funded Warrants to purchase up to 172,771 shares of the Issuer's common stock issued to the Reporting Person and (ii) December Pre-Funded Warrants to purchase up to 86,385 shares of the Issuer's common stock issued to the Conlin Family Foundation Trust of which the Reporting Person is a Trustee. On March 19, 2025, the Reporting Person acquired the following pre-funded warrants (the "March Pre-Funded Warrants" and together with the December Pre-Funded Warrants, the "Pre-Funded Warrants"): (i) March Pre-Funded Warrants to purchase up to 689,972 shares of the Issuer's common stock issued to the Reporting Person and (ii) March Pre-Funded Warrants to purchase up to 229,990 shares of the Issuer's common stock issued to the Conlin Family Foundation Trust of which the Reporting Person is a Trustee. The exercise of the Pre-Funded Warrants was subject to stockholder approval and the Issuer was obligated to use its reasonable best efforts to obtain stockholder approval of the exercise of the Pre-Funded Warrants in accordance with the rules of the Nasdaq Stock Market at the next annual meeting of the Issuer's stockholders which was held on June 18, 2025 (the "2025 Annual Meeting"). At the 2025 Annual Meeting, the stockholders of the Issuer approved the issuance of the Pre-Funded Warrants and shares of the Issuer's common stock issuable upon exercise thereof. The Pre-Funded Warrants are exercisable at $0.0005 per share and will terminate when exercised in full. Other than as described above, the Reporting Person does not have any present plan or proposal which relates to, or would result in any action with respect to, the matters listed in paragraphs (a) through (j) of Item 4 of Schedule 13D.